Wall Street Journal

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego-based ...
Seeking Alpha

Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
NBC Los Angeles

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Stream Los Angeles News for free, 24/7, wherever you are. On March 25, Illumina announced that Keith Meister (founder, managing partner and chief investment officer of Corvex Management) will join the ...
Times of San Diego

Illumina Expects Full-Year Sales from Core Segment to Decline on Biotech Funding Crunch

A sign on Illumina’s campus in San Diego. Reuters/Mike Blake San Diego-based gene sequencing machine maker Illumina this week forecast 2024 sales from its core segment to decline, a sign that subdued ...
San Diego Union-Tribune

China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s part ...
Times of San Diego

SD-Based Illumina’s Board of Directors Agrees to Spin Off GRAIL in June

Shareholders will receive one common share of GRAIL for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in ...
San Diego Union-Tribune

Illumina to cut $100M in costs to cope with China ban

Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene-sequencing ...
Nasdaq

Illumina (ILMN) to Spin Off GRAIL, Stock Gains

The gene sequencing machine maker Illumina (NASDAQ:ILMN) announced that its Board of Directors approved the spin-off of GRAIL. The separation is set to occur on June 24, 2024, with GRAIL trading ...
Yahoo Finance

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and ...
Reuters

Illumina sued by rival Element over gene-sequencing technology

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
Reuters

Illumina expects full-year sales from core segment to decline on biotech funding crunch

Aug 6 (Reuters) - Gene sequencing machine maker Illumina (ILMN.O), opens new tab on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued ...